RCAG
CHRS icon

Rehmann Capital Advisory Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Rehmann Capital Advisory Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		$850 Buy
+42
New +$850 ﹤0.01% 1585